Member Info for oogleflugal

According to their RNS the market for clinical depression is set to reach 19 billion by 20303. Seems rather a long way off, maybe too many threes or zeros. Clearly medical health plays an integral part of the productivity and well being of employees to make a successful company. The trouble has been the ease and incentives for doctors to randomly hand out a variety of ‘well being tablets. The point about diagnostics is to more accurately assess a patients needs and find taylor made solutions rather than what is convenient for the health care providers. The benefits to patients should be huge and the wastage of generalised prescription should enable massive savings. So healthier companies and more cost effective healthcare. Everyone benefits

My mistake . It’s a 1.2 million contract. Should pay for a tea break.

‘What happened?’ Well Easyp you have a lot to catch up on! Happy reading. Basically the usual overpaying for acquisitions and running g out of money. The ceo got fired after the last placing for reasons not explained. We have had joint interim CEO s who seem to have steadied the ship. The big backers remain strong. Today is the first contract news in eighteen months which sound encouraging but not much information in monetary terms. The offshoot Monument therapeutics ( 22 percent holding) has been doing very well and at clinical trials with a schizophrenic drug. The sp did drop to 26p after the Dr Stork fiasco but was beginning to recover till the last few weeks as everything seems to be in turmoil thanks to Trump. Winterlight are apparently translating the cog tests into Japanese which could mean there is need to come . 36p is a pretty good entry IMO but not for widows and orphans. DYO due diligence etc.

Never known a share go through the rinse cycle quite like this apart from some of those covid vaccination testing stocks back in the pandemic. Can’t say it’s not exciting! More seriously this company have a very special service to offer kidney transplant patients recovery. So they had better succeed.

Forgot to mention the great presentation. That was worth attending just to meet other investors and learn a bit more on the history about what went wrong and why and why this is set to go olaces

What is it with UBS trading in and out with 5 percent every other week. Somebody offloaded £2.50 worth of stock today, must be a tax dodge.

Alexandra Jackson of Rathbones talks about this on Vox markets. She sites orange disease ((not Trump) actual oranges as being a problem at the moment although the senile old git is doing his bit screw up the world economy. Obviously he wants everyone to buy one of his mates Teslas. Director resignations are always a drag. the market has clearly taken leave of its senses, not that it ever had any. I was going to buy at £4 but decided to wait for the new ISA share season on April 6th. Saved me a fortune so far just staying out of purchasing anything, never mind the tax shelter!

They’ve spent two years getting shot of legacy stuff that makes no money. Focus on the higher margin products. The other big plus is their manufacturing base in USA which has sparked some interest in the enzyme that plant because it circumnavigates the orange loonies tariffs. They are ahead on EBiTDA and cash generation expected to hit 20 million by year end. They can’t do a divi because they need £10 million float. So Imminent share buyback should increase EPS. The sp is plain daft like many stocks on AIM. 5 year plan to hit 80 million revenue by 2029 that’s without any profit making acquisition. If NHs was a big client I would be concerned. They never will be . They are in a great place for substantial recovery. If you agree buy if not sell. Simples. Everything carries risk. Some are better than others.

SB. We are in the silly season as far as tax year end and ISAs go. Feels like that since the new year to be honest. Apart from fund redemptions most institutional holders seem pretty rock solid as JB pointed out yesterday particularly with reference to EKF and Renx. Seems to be mostly retail investors with fingers in the panic button. Ok the director buys we’re not huge yesterday but they already have considerable skin in the game and have been in a closed period more or less since the sp started dropping here. I am looking to top up but waiting for the new ISA year allowance now. Absolutely no worry about FOMO on anything at the moment!

I attended the presentation yesterday evening. First time I have been to one of these events in about 15 years. I think and hope it was worth it! Only a dozen or so of us. Obviously a lot of work to do on EKF refocussing on areas of profitability to bring back £80 million revenue by 2029. Mostly positive, great cash generation and strong balance sheet with 17 million cash and counting. (£1 million generated in interest) . No idea why they want to do a small buyback, seems a total waste of cash and it never achieves anything in my experience. I get why they dont want to commit to a dividend. They are open to a profit making acquisition if it fits the portfolio. The new CeO quipped about how long Julian would let him speak for before Julian interrupted, which led to the 88 year old in the room asking if Julian was D Trump to much gafawing.

That is clearly one of the problems finding the right people to lead. That was one of the issues with Renx, which is why Julian came back to head that up again last year and was the largest participant in the placing because ‘its the best thing I have been involved with my whole career and I wasnt going to watch it slip away’. I dont believe he is a guy not to be trusted, i think he may have a problem entrusting others and hopefully will stay more actively involved. Interestingly and a little depressingly he explained all the problems in cracking NHS contracts and why they are heavily focussed in Europe and the US. Renx is very small and why they have focussed on NY, Texas and Florida where there are a higher populations of over 60s and people with kidney disease and presumably health insurance. Generally I felt much more positive about both that it will happen but its not going to happen over night. The markets are generally bananas across the world so I think its best to sit tight and watch as frustrating as that can be..

Great. Hoping to attend both meetings

Unfortunately it seems many brokers are not facilitating retail clients with the opportunity to take up placing.

Any thought that the government can do a better job by renationalising utilities and transport is delusional. They can’t even oversee them properly , allowing total abuse of dividend payments and bonuses with few penalties other than fining shareholders occasionally. That’s the problem. Privatising was perfect, that didn’t mean they should run riot over their customers.

‘Hard to believe’. The only thing will be hard to believe is if they actually deliver anything material. At the moment they can’t even deliver on Nanogenics clinical trial promised last year or the other bit of insignificance I cant even remember. Debt or dilution? Frankly I wouldn’t lend them a paper bag to puke in. Investing here is bit like one of those forms where you lend some money for house deposit but you have to sign a form saying you don’t expect it back!

I guess you’re not alone in that respect SB . I was fortunate not to latch on here till late last year, but a few uncomfortable positions elsewhere and not with the same prospects. Would hope we would be half way back at least in 12 to 18 months. It’s one of those things where I would hope it gathers momentum and then really snowballs especially with partnerships. Gl

Thanks SB. Yes I did get the names muddled up! Some disappointingly large sells today. Pretty weird market still . I last bought at 8.8p . Have been looking at many tempting opportunities . So far staying out, but this would be my first choice to add more .

Looks like it is a revised offer

Well done guys for hanging in . Griffiths must be kicking himself more than me!

Even bigger recovery from £3. Revamped with new technology. If they have been struggling with demand I am surprised it’s not been snapped up by someone with more desperate needs and much deeper pockets like one of their oil major clients. They are outsourcing the manufacturing anyway.

Know more on Tuesday